Spots Global Cancer Trial Database for Metronomic Chemotherapy in a Real-world Population of Advanced Breast Cancer Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Metronomic Chemotherapy in a Real-world Population of Advanced Breast Cancer Patients
Official Title: Metronomic Chemotherapy in a Real-world Population of Advanced Breast Cancer Patients
Study ID: NCT06373744
Conditions
Study Description
Brief Summary: The goal of this observational study is to learn about the effects of metronomic chemotherapy in advanced breast cancer patients. The main question it aims to answer is: How effective is metronomic chemotherapy in advanced breast cancer? Specific benefit groups of metronomic chemotherapy.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Shusen Wang, Guangzhou, Gangdong, China
Contact Details
Name: Shusen Wang, MD
Affiliation: Sun Yat-sen University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
